Schrodinger

Schrodinger, LLC. is a privately held company founded in 1990 and a leading provider of advanced molecular simulation and enterprise software solutions. As a pioneer in life sciences and materials research, Schrodinger has revolutionized drug discovery through cutting-edge molecular simulation technologies. The company’s mission is to improve human health and quality of life by developing, distributing, and applying advanced computational methods. Schrodinger's drug discovery platform integrates physics-based molecular simulation techniques with machine learning technologies. Compared to traditional drug development approaches, molecular simulation technology accelerates the drug development process. The platform includes a small molecule drug development suite, biologics suite, materials science suite, and more. Currently, many of Schrodinger's novel drugs under research have entered clinical stages. Two new oncology drugs co-developed with partners have received FDA approval.